OTC: SEOVF - Sernova Corp.

Altı ay boyunca karlılık: -35%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Sernova Corp.


Şirket hakkında Sernova Corp.

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

daha fazla ayrıntı
Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells;a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform; and research collaboration with AstraZeneca PLC to evaluate novel potential therapeutic cell applications. The company was incorporated in 1998 and is headquartered in London, Canada.

IPO date 1999-04-12
ISIN CA81732W1041
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://www.sernova.com
Цена ао 0.11
Günlük fiyat değişimi: 0% (0.13)
Haftalık fiyat değişimi: 0% (0.13)
Aylık fiyat değişimi: +8.33% (0.12)
3 ayda fiyat değişimi: -13.33% (0.15)
Altı ayda fiyat değişimi: -35% (0.2)
Yıllık fiyat değişimi: -61.76% (0.34)
3 yılda fiyat değişimi: -89.34% (1.22)
5 yılda fiyat değişimi: +73.33% (0.075)
Yılbaşından bu yana fiyat değişimi: -13.33% (0.15)

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV -5.93 0
P/E 0 0
EV/EBITDA 0 0
Toplam: 2.5

Yeterlik

İsim Anlam Seviye
ROA, % -217.26 0
ROE, % 14564.17 10
Toplam: 1.67

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA 0 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 559.42 10
karlılık EPS, % 387.46 10
Toplam: 8



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Christopher Barnes Vice President of Investor Relations 119.98k
Dr. Frank Shannon M.D. Vice President of Clinical Development & Regulatory Affairs 255.85k
Ms. Cynthia Pussinen CEO & Director 404.17k
Mr. Douglas Maret Chief Science Officer N/A
Dr. Modestus Obochi M.B.A., Ph.D. Chief Business Officer 221.36k
Mr. Nicholas J. Rossettos CPA, M.B.A. Interim Chief Financial Officer N/A 1966 (59 yıllar)
Mr. Jonathan M. N. Rigby M.B.A., MBA Executive Chairman 1968 (57 yıllar)

Adres: Canada, London, The Stiller Centre - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.sernova.com